Fundraising Fox

Beth Seidenberg

Investor

Managing Director at Westlake Village BioPartners · General Partner at Kleiner Perkins

Westlake Village, California, United States

Writes $100K – $5M checks

Midas 2020 · #54Midas 2019 · #59Midas 2018 · #62Midas 2016 · #98Midas 2015 · #91

About

Beth Seidenberg is a board‑certified physician and immunologist with rare drug‑development experience—helping develop Singulair at NIH and large pharma—who holds senior roles and chairs therapeutic boards shaping LA biotech ecosystem.

Invests in

AI & Machine LearningBiotechHealthtechMedical Devices

Experience

  1. Westlake Village BioPartnersCo-founding Managing Director at Westlake Village BioPartnerscurrent2018 — presentWestlake Village, California
  2. Kleiner PerkinsGeneral Partnercurrent2005 — presentMenlo Park, CA
  3. AmgenSenior Vice President2002 — 2005Thousand Oaks
  4. Bristol Myers SquibbSenior Vice President, Global Development2001 — 2002
  5. Bristol Myers SquibbSenior Vice President, Clinical Development & Life Cycle Management2000 — 2001
  6. Bristol Myers SquibbVice President, Clinical Immunology/Pulmonary/Dermatology2000
  7. MerckVice President, Pulmonary-Immunology1998 — 2000
  8. MerckExecutive Director1996 — 1998
  9. MerckSenior Director1993 — 1996
  10. MerckDirector, Clinical Pharmacology1991 — 1993
  11. MerckAssociate Director, Clinical Pharmacology1989 — 1991

Education

  1. Barnard CollegeBachelor of Science (BS)
  2. University of Miami Miller School of MedicineDoctor of Medicine (MD)
  3. The Johns Hopkins University School of MedicinePost Graduate Training
  4. National Institutes of HealthPost Graduate Training

Skills & more

Start-ups18Business Strategy20Life Sciences9Entrepreneurship7Business Development6Venture Capital8Strategy10Leadership8Strategic Planning17Management10

From Beth's professional profile.

Same school

Shared employers

Also worked at Westlake Village BioPartners9

+ 3 more

Also worked at Amgen53

+ 47 more

Also worked at Bristol Myers Squibb45

+ 39 more

Also worked at Merck90

+ 84 more

Deals · 17

Star Therapeutics LLCBoard seat

via Westlake Village BioPartners · filed Oct 2025 · $125M raise

Latigo BiotherapeuticsBoard seat

via Westlake Village BioPartners · filed Feb 2025 · $150M raise

Arsenal BiosciencesBoard seat

via Westlake Village BioPartners · filed Sep 2024 · $325.4M raise

Arsenal BiosciencesBoard seat

via Kleiner Perkins · filed Sep 2022 · $33M raise

Vera TherapeuticsBoard seat

via Kleiner Perkins · filed Feb 2021 · $70.7M raise

3-V BiosciencesBoard seat

via Westlake Village BioPartners · filed Jan 2021 · $80M raise

Tmunity TherapeuticsBoard seat

via Kleiner Perkins · filed Oct 2019 · $75M raise

FLX BioBoard seat

via Kleiner Perkins · filed Jun 2019 · $67.1M raise

KinsaBoard seat

via Kleiner Perkins · filed Apr 2018 · $14M raise

Breathe TechnologiesBoard seat

via Kleiner Perkins · filed Sep 2017 · $8.5M raise

Hixme Insurance SolutionsBoard seat

via Kleiner Perkins · filed Oct 2016 · $16M raise

Cell Design LabsBoard seat

via Kleiner Perkins · filed Jun 2016 · $22.9M raise

TesaroBoard seat

via Kleiner Perkins · filed Mar 2016 · $155M raise

LivongoBoard seat

via Kleiner Perkins · filed Apr 2015 · $20M raise

Flexus BiosciencesBoard seat

via Kleiner Perkins · filed Mar 2015 · $15.2M raise

AuxogynBoard seat

via Kleiner Perkins · filed Mar 2015 · $41M raise

3-V BiosciencesBoard seat

via Kleiner Perkins · filed Mar 2015 · $35M raise

Attribution from SEC filings, press coverage, and firm rosters.

Colleagues at Westlake Village BioPartners

Network11

Investors connected to Beth in public investor directories — a warm-intro map.